This is the author accepted manuscript. The final version is available from the publisher via the DOI in this record.Background: The UK lags behind many European countries in terms of cancer survival. Initiatives to address this disparity have focused on barriers to presentation, symptom recognition, and referral for specialist investigation. Selection of patients for further investigation has come under particular scrutiny, although preferences for referral thresholds in the UK population have not been studied. We investigated preferences for diagnostic testing for colorectal, lung, and pancreatic cancers in primary-care attendees. Methods: In a vignette-based study, researchers recruited individuals aged at least 40 years attending 26 gen...
BACKGROUND: Expediting cancer diagnosis may be achieved by targeted decreases in referral thresholds...
BACKGROUND: Shared decision making is a stated aim of several healthcare systems. In the area of can...
OBJECTIVES: Cancer survival and stage of disease at diagnosis and treatment vary widely across Europ...
This is the author accepted manuscript. The final version is available from Elsevier via the DOI in ...
SummaryBackgroundThe UK lags behind many European countries in terms of cancer survival. Initiatives...
SummaryBackgroundThe UK lags behind many European countries in terms of cancer survival. Initiatives...
BACKGROUND: The challenge for GPs when assessing whether to refer a patient for cancer investigation...
BACKGROUND: Contacting a doctor for advice when experiencing a potential cancer symptom is an import...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
Background: Contacting a doctor for advice when experiencing a potential cancer symptom is an import...
Objectives: Cancer survival rates vary widely between European countries, with differences in timeli...
Objectives: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
BACKGROUND: Expediting cancer diagnosis may be achieved by targeted decreases in referral thresholds...
BACKGROUND: Expediting cancer diagnosis may be achieved by targeted decreases in referral thresholds...
BACKGROUND: Shared decision making is a stated aim of several healthcare systems. In the area of can...
OBJECTIVES: Cancer survival and stage of disease at diagnosis and treatment vary widely across Europ...
This is the author accepted manuscript. The final version is available from Elsevier via the DOI in ...
SummaryBackgroundThe UK lags behind many European countries in terms of cancer survival. Initiatives...
SummaryBackgroundThe UK lags behind many European countries in terms of cancer survival. Initiatives...
BACKGROUND: The challenge for GPs when assessing whether to refer a patient for cancer investigation...
BACKGROUND: Contacting a doctor for advice when experiencing a potential cancer symptom is an import...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
Background: Contacting a doctor for advice when experiencing a potential cancer symptom is an import...
Objectives: Cancer survival rates vary widely between European countries, with differences in timeli...
Objectives: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
OBJECTIVES: Cancer survival rates vary widely between European countries, with differences in timeli...
BACKGROUND: Expediting cancer diagnosis may be achieved by targeted decreases in referral thresholds...
BACKGROUND: Expediting cancer diagnosis may be achieved by targeted decreases in referral thresholds...
BACKGROUND: Shared decision making is a stated aim of several healthcare systems. In the area of can...
OBJECTIVES: Cancer survival and stage of disease at diagnosis and treatment vary widely across Europ...